Literature DB >> 17998090

Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [111In]DTPA-hEGF.

Meiduo Hu1, Deborah Scollard, Conrad Chan, Paul Chen, Katherine Vallis, Raymond M Reilly.   

Abstract

INTRODUCTION: Our objective was to evaluate the effect of epidermal growth factor receptor(s) (EGFR) density on the importation and nuclear localization of 111In-labeled diethylenetriaminepentaacetic acid human epidermal growth factor ([111In]DTPA-hEGF) in breast cancer (BC) cells in vitro and in tumor xenografts and normal tissues in vivo in athymic mice, as well as on its cytotoxicity and tumor and normal-tissue distribution.
METHODS: The internalization and nuclear importation of [111In]DTPA-hEGF were measured in MCF-7, MDA-MB-231, BT-474 and MDA-MB-468 BC cells (10(4), 2 x 10(5), 6 x 10(5) and 10(6) EGFR/cell, respectively). The molecular size (Mr) distribution and immunoreactivity of nuclear radioactivity were characterized. Tumor and normal-tissue uptake of [111In]DTPA-hEGF in athymic mice implanted subcutaneously with BC xenografts were compared. Nuclear radioactivity in the tumor, lungs, liver, kidneys, spleen and colon was measured.
RESULTS: There was a direct association between EGFR density and the nuclear localization of [111In]DTPA-hEGF in BC cells; nuclear importation approached saturation at 6 x 10(5) EGFR/cell. Almost all nuclear radioactivities exhibited an Mr of >100 kDa; immunoreactivity with anti-hEGF, anti-EGFR and anti-importin beta 1 antibodies was detected. The efflux of nuclear radioactivity was slowest for MDA-MB-468 cells. Cytotoxicity was correlated with EGFR expression. Uptake was greater in MDA-MB-468 than in MCF-7 xenografts and improved with preinjection of a 100-fold excess of unlabeled DTPA-hEGF. Nuclear importation was higher in liver, kidney and spleen cells than in tumor cells.
CONCLUSION: [111In]DTPA-hEGF is translocated to the nucleus of BC cells complexed with EGFR and importin beta1. Nuclear importation and cytotoxicity are effected by EGFR density. The absence of hepatic and renal toxicities in [111In]DTPA-hEGF cannot be explained by a low efficiency of nuclear importation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17998090     DOI: 10.1016/j.nucmedbio.2007.06.010

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  13 in total

1.  Control of solid tumor growth in mice using EGF receptor-targeted RNA replicase-based plasmid DNA.

Authors:  B Leticia Rodriguez; Xinran Li; Kaoru Kiguchi; John DiGiovanni; Evan C Unger; Zhengrong Cui
Journal:  Nanomedicine (Lond)       Date:  2012-02-02       Impact factor: 5.307

Review 2.  Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.

Authors:  Thaddeus J Wadas; Edward H Wong; Gary R Weisman; Carolyn J Anderson
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

3.  Blocking EGFR in the liver improves the tumor-to-liver uptake ratio of radiolabeled EGF.

Authors:  Heewa Kareem; Karl Sandström; Ronny Elia; Lars Gedda; Matti Anniko; Hans Lundqvist; Marika Nestor
Journal:  Tumour Biol       Date:  2010-01-30

4.  PET imaging of EGF receptors using [18F]FBEM-EGF in a head and neck squamous cell carcinoma model.

Authors:  Weihua Li; Gang Niu; Lixin Lang; Ning Guo; Ying Ma; Dale O Kiesewetter; Joseph M Backer; Baozhong Shen; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11-23       Impact factor: 9.236

5.  Manipulating the lateral diffusion of surface-anchored EGF demonstrates that receptor clustering modulates phosphorylation levels.

Authors:  D Stabley; S Retterer; S Marshall; K Salaita
Journal:  Integr Biol (Camb)       Date:  2013-04       Impact factor: 2.192

6.  Chaperone-targeting cytotoxin and endoplasmic reticulum stress-inducing drug synergize to kill cancer cells.

Authors:  Joseph M Backer; Arcadius V Krivoshein; Carl V Hamby; John Pizzonia; Kenneth S Gilbert; Yonaton S Ray; Harrison Brand; Adrienne W Paton; James C Paton; Marina V Backer
Journal:  Neoplasia       Date:  2009-11       Impact factor: 5.715

7.  Nuclear localization of orphan receptor protein kinase (Ror1) is mediated through the juxtamembrane domain.

Authors:  Hsiao-Chun Tseng; Ping-Chiang Lyu; Wen-Chang Lin
Journal:  BMC Cell Biol       Date:  2010-06-30       Impact factor: 4.241

8.  Stroma targeting nuclear imaging and radiopharmaceuticals.

Authors:  Dinesh Shetty; Jae-Min Jeong; Hyunsuk Shim
Journal:  Int J Mol Imaging       Date:  2012-05-21

9.  PARP-Targeted Auger Therapy in p53 Mutant Colon Cancer Xenograft Mouse Models.

Authors:  Thomas Wilson; Giacomo Pirovano; Gu Xiao; Zachary Samuels; Sheryl Roberts; Tara Viray; Navjot Guru; Pat Zanzonico; Marc Gollub; Naga Vara Kishore Pillarsetty; Thomas Reiner; Jill Bargonetti
Journal:  Mol Pharm       Date:  2021-07-28       Impact factor: 5.364

10.  EGF-coated gold nanoparticles provide an efficient nano-scale delivery system for the molecular radiotherapy of EGFR-positive cancer.

Authors:  Lei Song; Nadia Falzone; Katherine A Vallis
Journal:  Int J Radiat Biol       Date:  2016-03-21       Impact factor: 2.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.